Literature DB >> 19030519

Effects of treatment on the overall functioning of children with ADHD.

Lily Hechtman1.   

Abstract

Entities:  

Year:  2005        PMID： 19030519      PMCID： PMC2547092     

Source DB:  PubMed          Journal:  Can Child Adolesc Psychiatr Rev        ISSN： 1716-9119


× No keyword cloud information.
  4 in total

1.  Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial.

Authors:  D J Cox; R L Merkel; B Kovatchev; R Seward
Journal:  J Nerv Ment Dis       Date:  2000-04       Impact factor: 2.254

2.  A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder.

Authors:  Joseph Biederman; Frank A Lopez; Samuel W Boellner; Mark C Chandler
Journal:  Pediatrics       Date:  2002-08       Impact factor: 7.124

3.  Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study.

Authors:  Daniel J Cox; R Lawrence Merkel; Jennifer Kim Penberthy; Boris Kovatchev; Cheryl S Hankin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-03       Impact factor: 8.829

4.  Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

Authors:  James T McCracken; Joseph Biederman; Laurence L Greenhill; James M Swanson; James J McGough; Thomas J Spencer; Kelly Posner; Sharon Wigal; Caroly Pataki; Yuxin Zhang; Simon Tulloch
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-06       Impact factor: 8.829
  4 in total
  5 in total

Review 1.  A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.

Authors:  Martin A Katzman; Tia Sternat
Journal:  CNS Drugs       Date:  2014-11       Impact factor: 5.749

Review 2.  The role of neuropsychological assessment in the functional outcomes of children with ADHD.

Authors:  Alison E Pritchard; Carly A Nigro; Lisa A Jacobson; E Mark Mahone
Journal:  Neuropsychol Rev       Date:  2011-11-15       Impact factor: 7.444

3.  Personalized Medication Response Prediction for Attention-Deficit Hyperactivity Disorder: Learning in the Model Space vs. Learning in the Data Space.

Authors:  Hin K Wong; Paul A Tiffin; Michael J Chappell; Thomas E Nichols; Patrick R Welsh; Orla M Doyle; Boryana C Lopez-Kolkovska; Sarah K Inglis; David Coghill; Yuan Shen; Peter Tiño
Journal:  Front Physiol       Date:  2017-04-11       Impact factor: 4.566

Review 4.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09

Review 5.  Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy.

Authors:  James C Ermer; Michael Pennick; Glen Frick
Journal:  Clin Drug Investig       Date:  2016-05       Impact factor: 2.859
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.